ATE553781T1 - Lineare selbsteliminierende oligomere - Google Patents

Lineare selbsteliminierende oligomere

Info

Publication number
ATE553781T1
ATE553781T1 AT08009514T AT08009514T ATE553781T1 AT E553781 T1 ATE553781 T1 AT E553781T1 AT 08009514 T AT08009514 T AT 08009514T AT 08009514 T AT08009514 T AT 08009514T AT E553781 T1 ATE553781 T1 AT E553781T1
Authority
AT
Austria
Prior art keywords
eliminating
oligomers
linear self
oligomer
self
Prior art date
Application number
AT08009514T
Other languages
English (en)
Inventor
Andre Warnecke
Original Assignee
Ktb Tumorforschungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ktb Tumorforschungs Gmbh filed Critical Ktb Tumorforschungs Gmbh
Application granted granted Critical
Publication of ATE553781T1 publication Critical patent/ATE553781T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A61K47/556—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells enzyme catalyzed therapeutic agent [ECTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT08009514T 2008-05-23 2008-05-23 Lineare selbsteliminierende oligomere ATE553781T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08009514A EP2123305B1 (de) 2008-05-23 2008-05-23 Lineare selbsteliminierende Oligomere

Publications (1)

Publication Number Publication Date
ATE553781T1 true ATE553781T1 (de) 2012-05-15

Family

ID=39800619

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08009514T ATE553781T1 (de) 2008-05-23 2008-05-23 Lineare selbsteliminierende oligomere

Country Status (4)

Country Link
US (1) US8597631B2 (de)
EP (1) EP2123305B1 (de)
AT (1) ATE553781T1 (de)
WO (1) WO2009141050A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014133620A2 (en) 2012-12-07 2014-09-04 University Of Washington Through Its Center For Commercialization Thermally-activated self-immolative materials
WO2015081891A1 (en) 2013-12-06 2015-06-11 Baikang (Suzhou) Co., Ltd Bioreversable promoieties for nitrogen-containing and hydroxyl-containing drugs
WO2017129818A1 (de) * 2016-01-29 2017-08-03 Humboldt-Universität Zu Berlin Linkermolekül und verwendung desselben in verfahren zur reinigung von peptiden
US12624064B2 (en) 2016-01-29 2026-05-12 Gyros Protein Technologies AB Linker molecule and use thereof in methods for purifying peptides
EP3844143B1 (de) * 2018-08-27 2024-01-17 Gyros Protein Technologies AB Spurlose, reduktiv spaltbare linker-moleküle zur peptidreinigung
CN113929599B (zh) * 2020-07-08 2022-07-15 中国科学技术大学 一种精确嵌段聚合物纳米组装体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004043493A1 (en) * 2002-11-14 2004-05-27 Syntarga B.V. Prodrugs built as multiple self-elimination-release spacers
US20060269480A1 (en) * 2005-05-31 2006-11-30 Ramot At Tel Aviv University Ltd. Multi-triggered self-immolative dendritic compounds
WO2008053479A1 (en) * 2006-10-30 2008-05-08 Ramot At Tel Aviv University Ltd. Self-immolative polymers

Also Published As

Publication number Publication date
US20120270937A1 (en) 2012-10-25
WO2009141050A2 (en) 2009-11-26
US8597631B2 (en) 2013-12-03
WO2009141050A3 (en) 2010-01-14
EP2123305A1 (de) 2009-11-25
EP2123305B1 (de) 2012-04-18

Similar Documents

Publication Publication Date Title
PL4015527T3 (pl) Rekombinowany fsh zawierający alfa 2,3- i alfa 2,6-sialilację
FR2915075B1 (fr) Article d'entretien.
NO20081160L (no) Benzimidazoltiofen forbindelser
BRPI0816104A2 (pt) Produtos de lentes de contato.
BRPI0809829A2 (pt) Composição, artigo e embalagem
NL2001352A1 (nl) Artikeltransportmiddel.
NL2000997A1 (nl) Artikeltransportmiddel.
NL2001268A1 (nl) Artikeltransportmiddel.
NL2000998A1 (nl) Artikeltransportmiddel.
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
DE602006020277D1 (de) Warenverpackung
WO2009141050A3 (en) Linear self-eliminating oligomers
CL2007002812A1 (es) Compuestos derivados de quinolina; composicion farmaceutica, utiles para inhibir el vih.
NL1031912A1 (nl) Gestapeld ontlaatsysteem.
CY1117599T1 (el) Σουλφοναμιδια για την προληψη του διαβητη
PT2012701E (pt) Embalagem destacável para a esterilização
ATE445653T1 (de) Säuregruppenhaltige kondensationsprodukte
NO20091386L (no) Fenyloksyanilinderivater
EP2098538A4 (de) Molekulares modul
JP2006176755A5 (de)
NO20084671L (no) Peptidforbindelse med biologisk aktivite, dets tillaging og dets anvedelser
UA13006S (uk) Етикетка для томатної продукції
ITBO20060704A1 (it) Carrello per dispositivi di confezionamento.
UA15789S (uk) Контейнер транспортний кт-2,0
ITTO20050015U1 (it) Oggetto promozionale, particolarmente articolo di cartoleria.